These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Ethnicity delineates different genetic pathways in malignant glioma. Chen P; Aldape K; Wiencke JK; Kelsey KT; Miike R; Davis RL; Liu J; Kesler-Diaz A; Takahashi M; Wrensch M Cancer Res; 2001 May; 61(10):3949-54. PubMed ID: 11358811 [TBL] [Abstract][Full Text] [Related]
4. [Mutations of p53 gene in 41 cases of human brain gliomas]. Cui W; Kong X; Cao HL; Wang X; Gao JF; Wu RL; Wang XC Ai Zheng; 2008 Jan; 27(1):8-11. PubMed ID: 18184456 [TBL] [Abstract][Full Text] [Related]
5. Incidence and timing of p53 mutations during astrocytoma progression in patients with multiple biopsies. Watanabe K; Sato K; Biernat W; Tachibana O; von Ammon K; Ogata N; Yonekawa Y; Kleihues P; Ohgaki H Clin Cancer Res; 1997 Apr; 3(4):523-30. PubMed ID: 9815715 [TBL] [Abstract][Full Text] [Related]
6. p53 autoantibodies can be indicative of the development of breast cancer relapse. Regele S; Vogl FD; Kohler T; Kreienberg R; Runnebaum IB Anticancer Res; 2003; 23(1B):761-4. PubMed ID: 12680180 [TBL] [Abstract][Full Text] [Related]
7. [Prognostic significance of p53 autoantibodies in serum of patients with breast carcinoma]. Huober J; Sprenger H; Costa SD; Zentgraf H; Schmid H; Kaufmann M; Bastert G Zentralbl Gynakol; 1996; 118(10):560-4. PubMed ID: 8999710 [TBL] [Abstract][Full Text] [Related]
8. Detection of p53 gene mutations in human brain tumors by single-strand conformation polymorphism analysis of polymerase chain reaction products. Mashiyama S; Murakami Y; Yoshimoto T; Sekiya T; Hayashi K Oncogene; 1991 Aug; 6(8):1313-8. PubMed ID: 1886708 [TBL] [Abstract][Full Text] [Related]
9. Humoral response to p53 is associated with conserved domains II and IV mutations in human colorectal cancer: a case-control study in Taiwan. Wu CM; Tang R; Chen JR; Wu MC; Chien HT; Changchien CR; Hsieh LL Oncol Rep; 2004 Nov; 12(5):1045-51. PubMed ID: 15492791 [TBL] [Abstract][Full Text] [Related]
10. p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency. Frankel RH; Bayona W; Koslow M; Newcomb EW Cancer Res; 1992 Mar; 52(6):1427-33. PubMed ID: 1347252 [TBL] [Abstract][Full Text] [Related]
11. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytomas. Lang FF; Miller DC; Pisharody S; Koslow M; Newcomb EW Oncogene; 1994 Mar; 9(3):949-54. PubMed ID: 8108140 [TBL] [Abstract][Full Text] [Related]
12. Human gliomas with wild-type p53 express bcl-2. Alderson LM; Castleberg RL; Harsh GR; Louis DN; Henson JW Cancer Res; 1995 Mar; 55(5):999-1001. PubMed ID: 7867012 [TBL] [Abstract][Full Text] [Related]
13. Correlation of p53 immunoreactivity and sequencing in patients with glioma. Kyritsis AP; Xu R; Bondy ML; Levin VA; Bruner JM Mol Carcinog; 1996 Jan; 15(1):1-4. PubMed ID: 8561860 [TBL] [Abstract][Full Text] [Related]
14. Reappraisal of p53 mutations in human malignant astrocytic neoplasms by p53 functional assay: comparison with conventional structural analyses. Tada M; Iggo RD; Waridel F; Nozaki M; Matsumoto R; Sawamura Y; Shinohe Y; Ikeda J; Abe H Mol Carcinog; 1997 Mar; 18(3):171-6. PubMed ID: 9115587 [TBL] [Abstract][Full Text] [Related]
16. Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation. Winter SF; Minna JD; Johnson BE; Takahashi T; Gazdar AF; Carbone DP Cancer Res; 1992 Aug; 52(15):4168-74. PubMed ID: 1322237 [TBL] [Abstract][Full Text] [Related]
17. Mutations of the p53 gene in gliomas from Malay patients. Jafri A; Aziz MY; Ros S; Nizam I Med J Malaysia; 2003 Jun; 58(2):236-42. PubMed ID: 14569744 [TBL] [Abstract][Full Text] [Related]
18. Immunofluorometric assay of p53 protein versus sequencing of p53 exons 5 to 9 for the detection of p53 abnormalities in ovarian carcinoma. Lianidou ES; Levesque MA; Katsaros D; Angelopoulou K; Yu H; Genta F; Arisio R; Massobrio M; Bharaj B; Diamandis EP Anticancer Res; 1999; 19(1B):749-56. PubMed ID: 10216487 [TBL] [Abstract][Full Text] [Related]
19. p53 mutation is infrequent in clear cell carcinoma of the ovary. Ho ES; Lai CR; Hsieh YT; Chen JT; Lin AJ; Hung MH; Liu FS Gynecol Oncol; 2001 Feb; 80(2):189-93. PubMed ID: 11161858 [TBL] [Abstract][Full Text] [Related]
20. The circulating auto-antibodies to p53 protein in the follow-up of lymphoma patients. Jezersek B; Rudolf Z; Novakovic S Oncol Rep; 2001; 8(1):77-81. PubMed ID: 11115573 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]